12.07.2015 Views

Evaluación cuantitativa del riesgo de cáncer de mama

Evaluación cuantitativa del riesgo de cáncer de mama

Evaluación cuantitativa del riesgo de cáncer de mama

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

[Evaluación <strong>cuantitativa</strong> <strong><strong>de</strong>l</strong> <strong>riesgo</strong> <strong>de</strong> cáncer <strong>de</strong> <strong>mama</strong> - Dr. Fernando Gómez D.]104> Webb PM, Byrne C, Schnitt SJ, etal: Family history of breast cancer, ageand benign breast disease. Int J Cancer100:375-8, 2002.105> Connolly JL, Schnitt SJ: Benignbreast disease. Resolved and unresolvedissues. Cancer 71:1187-9, 1993.106> Jacobs TW, Byrne C, Colditz G, etal: Radial scars in benign breast-biopsyspecimens and the risk of breast cancer.N Engl J Med 340:430-6, 1999.107> Page DL, Salhany KE, Jensen RA,et al: Subsequent breast carcinoma riskafter biopsy with atypia in a breast papilloma.Cancer 78:258-66, 1996.108> Bondy ML, Lustba<strong>de</strong>r ED, HalabiS, et al: Validation of a breast cancer riskassessment mo<strong><strong>de</strong>l</strong> in women with a positivefamily history. J Natl Cancer Inst86:620-5, 1994.109> Spiegelman D, Colditz GA, HunterD, et al: Validation of the Gail et al.mo<strong><strong>de</strong>l</strong> for predicting individual breastcancer risk. J Natl Cancer Inst 86:600-7,1994.110> Rockhill B, Spiegelman D, ByrneC, et al: Validation of the Gail et al. mo<strong><strong>de</strong>l</strong>of breast cancer risk prediction andimplications for chemoprevention. J NatlCancer Inst 93:358-66, 2001.111> Claus EB, Risch N, Thompson WD:Autosomal dominant inheritance of earlyonsetbreast cancer. Implications for riskprediction. Cancer 73:643-51, 1994.112> Parmigiani G, Berry D, AguilarO: Determining carrier probabilitiesfor breast cancer-susceptibility genesBRCA1 and BRCA2. Am J Hum Genet62:145-58, 1998.113> Berry DA, Parmigiani G, SanchezJ, et al: Probability of carrying amutation of breast-ovarian cancer geneBRCA1 based on family history. J NatlCancer Inst 89:227-38, 1997.114> Seidman H, Stellman SD, MushinskiMH: A different perspective on breastcancer risk factors: some implicationsof the nonattributable risk. CA Cancer JClin 32:301-13, 1982.115> O’Shaughnessy JA, Kelloff GJ, GordonGB, et al: Treatment and preventionof intraepithelial neoplasia: an importanttarget for accelerated new agent <strong>de</strong>velopment.Clin Cancer Res 8:314-46, 2002.116> Bhathal PS, Brown RW, LesueurGC, et al: Frequency of benign and malignantbreast lesions in 207 consecutiveautopsies in Australian women. Br JCancer 51:271-8, 1985.117> Nielsen M, Thomsen JL, PrimdahlS, et al: Breast cancer and atypia amongyoung and middle-aged women: a studyof 110 medicolegal autopsies. Br J Cancer56:814-9, 1987.118> Dupont WD, Page DL: Risk factorsfor breast cancer in women with proliferativebreast disease. N Engl J Med312:146-51, 1985.119> Brown TA, Wall JW, ChristensenED, et al: Atypical hyperplasia in the eraof stereotactic core needle biopsy. J SurgOncol 67:168-73, 1998.120> Vogel VG, Costantino JP, WickerhamDL, et al: Re: tamoxifen for preventionof breast cancer: report of theNational Surgical Adjuvant Breast andBowel Project P-1 Study. J Natl CancerInst 94:1504, 2002.121> Tchou J HN, Ra<strong>de</strong>maker A et al.:Patient acceptance of tamoxifen as chemoprevention.ProcAm Soc Clin Oncol22:551, 2003.122> Dooley WC, Ljung BM, VeronesiU, et al: Ductal lavage for <strong>de</strong>tection ofcellular atypia in women at high riskfor breast cancer. J Natl Cancer Inst93:1624-32, 2001.123> Papanicolaou GN, Holmquist DG,Ba<strong>de</strong>r GM, et al: Exioliative cytology ofthe human mammary gland and its valuein the diagnosis of cancer and other diseasesof the breast. Cancer 11:377-409,1958.124> Buehring GC: Screening for breastatypias using exfoliative cytology. Cancer43:1788-99, 1979.125> Petrakis NL, Ernster VL, Sacks ST,et al: Epi<strong>de</strong>miology of breast fluid secretion:association with breast cancer riskfactors and cerumen type. J Natl CancerInst 67:277-84, 1981.126> Francescatti D WJ: Ductal Lavage:the learning curve. Proceeding of theFourth Annual Lynn Sage Symposium,2002; Chicago, IL. B6, 2002.127> Woods J, Ekbom GA: Managinghigh risk patients with ductal lavage.Proceeding of the Fourth Annual LynnSage Symposium, 2002; Chicago, IL.B5, 2002.128> Khan SA BC, Ramakrishnan R, etal: Proportion of cytologically evaluablesamples from duct lavage procedures.Proceeding of the American Associationof Cancer Research Frontiers in CancerResearch, 2002.129> Hoogerbrugge N, Bult P, <strong>de</strong> Widt-Levert LM, et al: High prevalence ofpremalignant lesions in prophylacticallyremoved breasts from women at hereditaryrisk for breast cancer. J Clin Oncol21:41-5, 2003.130> Evron E, Dooley WC, UmbrichtCB, et al: Detection of breast cancer cellsin ductal lavage fluid by methylationspecificPCR. Lancet 357:1335-6, 2001131> King BL, Crisi GM, Tsai SC, et al:Immunocytochemical analysis of breastcells obtained by ductal lavage. Cancer96:244-9, 2002.132> Khan SA RN, Baird C, et al: DuctalLavage finding in women with knownbreast cancer un<strong>de</strong>rgoing mastectomy.Proceeding of the San Antonio BreastCancer Symposium, 2002.133> Makita M, Sakamoto G, AkiyamaF, et al: Duct endoscopy and endoscopicbiopsy in the evaluation of nipple discharge.Breast Cancer Res Treat 18:179-87, 1991.134> Okazaki A, Okazaki M, Asaishi K,et al: Fiberoptic ductoscopy of the breast:a new diagnostic procedure for nippledischarge. Jpn J Clin Oncol 21:188-93,1991.135> Shen KW, Wu J, Lu JS, et al: Fiberopticductoscopy for patients with nippledischarge. Cancer 89:1512-9, 2000136> Dietz JR, Crowe JP, Grundfest S, etal: Directed duct excision by using mammaryductoscopy in patients with pathologicnipple discharge. Surgery 132:582-7; discussion 587-8, 2002.163ARCHIVO.indd 163 26/11/06 05:24:49

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!